(S)-5-bromo-indan-2-carbaldehyde → HCID 178458922、化合物
反応式
[NH2:1][C@@H:2]1[CH2:7][CH2:6][C@H:5]([N:8]2[C:12]3[CH:13]=[CH:14][C:15]([Cl:17])=[CH:16][C:11]=3[N:10]=[C:9]2[C:18]([OH:21])([CH3:20])[CH3:19])[CH2:4][CH2:3]1.[Br:22][C:23]1[CH:24]=[C:25]2[C:29](=[CH:30][CH:31]=1)[CH2:28][C@H:27]([CH:32]=O)[CH2:26]2>>[Br:22][C:23]1[CH:24]=[C:25]2[C:29](=[CH:30][CH:31]=1)[CH2:28][C@H:27]([CH2:32][NH:1][C@@H:2]1[CH2:3][CH2:4][C@H:5]([N:8]3[C:12]4[CH:13]=[CH:14][C:15]([Cl:17])=[CH:16][C:11]=4[N:10]=[C:9]3[C:18]([OH:21])([CH3:19])[CH3:20])[CH2:6][CH2:7]1)[CH2:26]2参加物
3
実験手順
This compound was prepared from the hydrochloride salt of cis-2-[1-(4-amino-cyclohexyl)-5-chloro-1H-benzoimidazol-2-yl]-propan-2-ol and (S)-5-bromo-indan-2-carbaldehyde. LC-MS showed a single peak, C26H31BrClN3O (m/e) calcd 515.1339, obsd 516.1 (M+H). 1H-NMR (CD3OD) □ 7.96 (d, 1H), 7.59 (s, 1H), 7.36 (s, 1H), 7.26 (d, 1H), 7.18 (d, 1H), 7.12 (d, 1H), 5.38 (m, 1H), 3.16 (m, 2H), 3.03 (br s, 1H), 2.67-2.83 (m, 7H), 2.07 (m, 2H), 1.72 (br s, 10H).
出典と根拠
- ORDレコード
- ord-bdfe48bc76664010ac152a9129034955
- 出典データセット
- uspto-grants-2010_01
- 特許番号